forecast

Argenx Phase II approvals rely on mechanism

The probability of approval for Argenx's pipeline drugs is around 60 to 70 percent rather than the industry's 10 percent, because the company understands the biology it targets and the patient difference it makes.

forecastpending

Speaker

Julia

Evidence Quote

“they are not 10%, they are look more like 60%, 70%”

Source

Argenx: Changing Lives with Llamas— Business Breakdowns
Created: 11/17/2026, 3:39:21 AM

Your notes

Loading notes...